IMAP partners in Spain and Germany advise Atrys on the acquisition of Swiss firm Radio-Onkologie Amsler AG
Atrys is a Spanish biomedical company dedicated to providing diagnostic services and medical treatments primarily for oncology patients
IMAP closed 140 M&A deals worth more than $5.2bn in the first three quarters of 2019. Consistent with IMAP’s track record, 29% of the deals were cross-border. Deals were closed across 14 different sectors, with Industrials, Technology, and Consumer & Retail the most represented.
Jurgis V. Oniunas, IMAP Chairman commented: "Despite the clouds gathering over the world economy, business owners worldwide continued to choose IMAP partners to guide them through some of their most important life decisions."
Atrys is a Spanish biomedical company dedicated to providing diagnostic services and medical treatments primarily for oncology patients
Founder and CEO Ragip Aydin will keep a significant stake in Raynet
WhitePress is a leading content marketing platform that assists advertising agencies and corporate clients in the creation and publication of high-quality content across the web, as well as tracking marketing campaign results